Justin Brogan

Justin Brogan

Justin Brogan
+1 617 570 1429

Justin Brogan is an associate in the firm’s Business Law department. He joined Goodwin in 2022.


Justin’s recent representations, among others, include:

Capital Markets and Mergers & Acquisitions:

  • Klaviyo in its $659 million initial public offering
  • HI-Bio in its up to $1.8 billion sale to Biogen 
  • Ultimate.ai in its sale to Zendesk
  • Veracode in its acquisition of Longbow Security
  • Xcoding Labs in its sale to Datadog
  • Verisma Systems in its acquisition of ScanSTAT Technologies
  • Zynerba Pharmaceuticals in its $60 million sale to Harmony Biosciences
  • RoadOne IntermodaLogistics in its sale to Ridgemont Equity Partners
  • CVA USA in its acquisition of Cardiovascular Associates of Kissimmee

Private Financings:

  • FamilyWell in its $4.25 million Series Seed financing
  • Novo Holdings in its $40 million Series E investment in Cleveland Diagnostics
  • Mantra Health in its $5 million Series A-1 financing
  • LifeArc in its Convertible Note investment in Ozlo Sleep
  • Bid Ventures in its SAFE financings 
  • Aptihealth in its $50 million Series B financing
  • Loom in its $40 million venture debt financing
  • Positive Development in its $13 million venture debt financing

Professional Activities

Justin is a member of the Boston Bar Association and Massachusetts LGBTQ Bar Association.

Professional Experience

Justin joined the firm as a summer associate in 2021. Additionally, during his third year of law school, Justin worked as a law clerk in the firm’s Technology and Life Sciences groups.




Boston University School of Law


Tufts University

(summa cum laude)



  • Massachusetts

Recognition & Awards

During law school, Justin was the recipient of Goodwin’s Wayne A. Budd & Marian A. Tse Scholarship.